Skip to content

The effect of oral beta blocker for analgesia and nociception index(ANI) monitoring

The effect of oral beta blocker for analgesia and nociception index(ANI) monitoring

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0008082
Enrollment
50
Registered
2023-01-04
Start date
2023-01-02
Completion date
Unknown
Last updated
2023-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Chonnam National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. American Society of Anesthesiology Physical Classification (ASA PS) 2 to 3 patients 2. Patients who voluntarily gave written consent to participate in this clinical trial

Exclusion criteria

Exclusion criteria: 1. Patients diagnosed with arrhythmia 2. Patients with a pacemaker 3. Patients being treated for chronic pain 4. Patients diagnosed with autonomic nervous system diseases such as epilepsy 5. If anticholinergic drugs or vasoconstrictors were used before or during surgery 6. Patients judged unsuitable by other researchers

Design outcomes

Primary

MeasureTime frame
Differences in ANI monitor measurements at the same 4-time points between the two groups

Secondary

MeasureTime frame
Blood pressure, pulse rate, effect site concentration of Remifentanil

Countries

Korea, Republic of

Contacts

Public ContactJoungmin Kim

Chonnam National University Hospital

tca77@hanmail.net+82-62-220-6893

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026